Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2013 Dec;19(12):989-98.

Generic initiation and antidepressant therapy adherence under Medicare Part D

Yuhua Bao  1 , Andrew M Ryan, Huibo Shao, Harold Alan Pincus, Julie M Donohue
Affiliations

Generic initiation and antidepressant therapy adherence under Medicare Part D

Yuhua Bao et al. Am J Manag Care. 2013 Dec.

Abstract

Objectives: To assess the effect of initiating antidepressant therapy with a generic prescription on adherence to antidepressant therapy among Medicare patients. A second objective is to assess how the effect might be moderated by the Medicare Part D coverage gap.

Study design and methods: Adherence to antidepressant therapy was measured by (a lack of) disruption in medication use defined by a gap of 30 days or more in antidepressant possession and monthly days of possession, both measured over 180 days since antidepressant initiation. We used a 5% random sample of Medicare fee-for-service beneficiaries who received a new depression diagnosis in the first half of 2007 and initiated antidepressant therapy within 60 days (n = 16,778). We estimated a Cox proportional hazard model for antidepressant disruption and a mixedeffects linear model for monthly possession. All analyses were stratified by 4 cohorts defined by Part D low-income subsidy (LIS) status and Medicare entitlement (aged vs disabled).

Results: Generic initiation was associated with improved adherence among all 4 cohorts, with a stronger effect among the non-LIS patients. Hazard ratios for antidepressant disruption ranged from 0.71 (95% confidence interval [CI], 0.53-0.96) among non-LIS, disabled patients to 0.88 (95% CI, 0.79-0.98) among LIS, aged patients. Generic initiation was associated with increases in days of monthly possession in all 4 cohorts and an additional benefit during the coverage gap for non-LIS patients.

Conclusions: Generic initiation can be an important tool to improve adherence to antidepressant treatment among Medicare patients and to mitigate the negative effects of the Part D coverage gap.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Survival curves for disruption in antidepressant therapy by disability status and generic status of first antidepressant. LIS – Low Income Subsidy
Figure 2
Figure 2
Monthly days of antidepressant possession, by disability status and generic status of first antidepressant LIS – Low Income Subsidy
See this image and copyright information in PMC

References

    1. Stagnitti MN. The Top Five Therapeutic Classes of Outpatient Prescription Drugs Ranked by Total Expense for Adults Age 18 and Older in the U.S. Civilian Noninstitutionalized Population, 2004. Rockville, MD: Agency for Healthcare Research and Quality; 2006.
    1. Olfson M, Marcus SC. National Patterns in Antidepressant Medication Treatment. Arch Gen Psychiatry. 2009 Aug 1;66(8):848–856. - PubMed
    1. Depression Guideline Panel. Depression in Primary Care. Treatment of Major Depression. Vol. 2. US Department of Health and Human Services; Rockville, MD: Agency for Health Care Policy and Research; 1993.
    1. American Psychiatric Association. Practice Guideline for the Treatment of Patients With Major Depressive Disorder. 3. Arlington, VA: 2010.
    1. National Committee for Quality Assurance. The State of Health Care Quality. Reform, the Quality Agenda and Resourse Use. 2010.

Publication types